STIP1 and metastatic malignant neoplasm in the lymph nodes: A recent meta-analysis suggests that high STIP1 expression is significantly associated with shorter overall survival, early lymph node metastasis and more advanced clinical stage compared with low STIP1 expression in six studied cancer types (35).